Keraflox
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
A drug brand. The brand makes an oral antibiotic containing the active pharmaceutical ingredient Prulifloxacin which is used for the treatment of urinary tract infections and chronic bronchitis.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
- Milan
- Italy
Keraflox Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Keraflox‘s full profile, request access.
Request full access to PitchBookKeraflox Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Keraflox‘s full profile, request access.
Request full access to PitchBook